Minimal Residual Disease Market Analysis: The Rising Role of Liquid...

added blog Other

2026-10-13 10:22:16 -

Minimal Residual Disease Market Analysis: The Rising Role of Liquid Biopsy and Molecular Diagnostics

The minimal residual disease market is drawing growing attention from diagnostic developers, laboratories and oncology providers seeking earlier, more precise signals of treatment response. According to Polaris Market Research, the global MRD testing market was valued at USD 2.38 billion in 2025 and is expected to record a CAGR of 13.1% from 2026 to 2034, with a 2026 estimate of USD 2.69...

0 Comments 0 Shares 25 Views 0 Reviews